News

2025

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics

Quotient Therapeutics 04.29.2025

Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare

Etiome 04.24.2025

Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease

Repertoire® Immune Medicines 04.23.2025

Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease

Valo 04.01.2025

Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science

Lila Sciences 03.10.2025

Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health

YourBio Health 02.19.2025

Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation

01.23.2025

Valo Health and Novo Nordisk Expand Collaboration to Discover and Develop Novel Treatments for Cardiometabolic Diseases

01.08.2025

Loading